These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 838848)

  • 21. Somatostatin does not alter insulin-mediated glucose disposal.
    Meneilly GS; Elahi D; Minaker KL; Rowe JW
    J Clin Endocrinol Metab; 1987 Aug; 65(2):364-7. PubMed ID: 2885337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of glucocorticoids on hepatic sensitivity to insulin and glucagon in man.
    Dirlewanger M; Schneiter PH; Paquot N; Jequier E; Rey V; Tappy L
    Clin Nutr; 2000 Feb; 19(1):29-34. PubMed ID: 10700531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of the hepatic sympathetic nerves in the regulation of net hepatic glucose uptake and the mediation of the portal glucose signal.
    Dicostanzo CA; Dardevet DP; Neal DW; Lautz M; Allen E; Snead W; Cherrington AD
    Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E9-E16. PubMed ID: 16105863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside renders glucose output by the liver of the dog insensitive to a pharmacological increment in insulin.
    Camacho RC; Lacy DB; James FD; Donahue EP; Wasserman DH
    Am J Physiol Endocrinol Metab; 2005 Dec; 289(6):E1039-43. PubMed ID: 16046457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of an acute elevation of NEFA concentrations on glucagon-stimulated hepatic glucose output.
    Everett-Grueter C; Edgerton DS; Donahue EP; Vaughan S; Chu CA; Sindelar DK; Cherrington AD
    Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E449-59. PubMed ID: 16608886
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperglycemia inhibits glucose production in man independent of changes in glucoregulatory hormones.
    Sacca L; Hendler R; Sherwin RS
    J Clin Endocrinol Metab; 1978 Nov; 47(5):1160-3. PubMed ID: 400737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of insulin at two dose levels on gluconeogenesis from alanine in fasting man.
    Chiasson JL; Atkinson RL; Cherrington AD; Keller U; Sinclair-Smith BC; Lacy WW; Liljenquist JE
    Metabolism; 1980 Sep; 29(9):810-8. PubMed ID: 6997676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Persistent effect of sustained hyperglucagonemia on glucose production in man.
    Rizza RA; Gerich JE
    J Clin Endocrinol Metab; 1979 Feb; 48(2):352-5. PubMed ID: 429489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Direct assessment of splanchnic uptake and metabolic effects of human and porcine insulin.
    Saccà L; Orofino G; Petrone A; Vigorito C
    J Clin Endocrinol Metab; 1984 Aug; 59(2):191-6. PubMed ID: 6145721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-3, and IGF-I in insulin-dependent diabetes.
    Brismar K; Fernqvist-Forbes E; Wahren J; Hall K
    J Clin Endocrinol Metab; 1994 Sep; 79(3):872-8. PubMed ID: 7521354
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of verapamil on basal and glucagon-dependent splanchnic glucose metabolism and insulin secretion in man.
    Gasić S; Bratusch-Marrain P; Waldhäusl W; Korn A
    Int J Clin Pharmacol Ther Toxicol; 1988 Jan; 26(1):36-40. PubMed ID: 3042640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The essentiality of insulin and the role of glucagon in regulating glucose utilization and production during strenuous exercise in dogs.
    Vranic M; Kawamori R; Pek S; Kovacevic N; Wrenshall GA
    J Clin Invest; 1976 Feb; 57(2):245-55. PubMed ID: 1254723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Islet hormonal regulation of glucose turnover during exercise in type 1 diabetes.
    Shilo S; Sotsky M; Shamoon H
    J Clin Endocrinol Metab; 1990 Jan; 70(1):162-72. PubMed ID: 1967178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of tolbutamide and hepatic extraction of insulin and glucagon and hepatic glucose output in anesthetized dogs.
    Ishida T; Chou MC; Lewis RM; Hartley CJ; Entman M; Field JB
    Endocrinology; 1981 Aug; 109(2):443-50. PubMed ID: 7018888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gluconeogenesis from alanine in normal postabsorptive man. Intrahepatic stimulatory effect of glucagon.
    Chiasson JL; Liljenquist JE; Sinclair-Smith BC; Lacy WW
    Diabetes; 1975 Jun; 24(6):574-84. PubMed ID: 1140513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of continuous and pulsatile insulin delivery on net hepatic glucose uptake.
    Grubert JM; Lautz M; Lacy DB; Moore MC; Farmer B; Penaloza A; Cherrington AD; McGuinness OP
    Am J Physiol Endocrinol Metab; 2005 Aug; 289(2):E232-40. PubMed ID: 15755768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pancreatic glucagon and C-peptide secretion during hyperinsulinemia in euglycemic glucose clamp with or without somatostatin infusion in normal man.
    Wu MS; Ho LT
    Horm Metab Res; 1987 Jun; 19(6):253-6. PubMed ID: 2887501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia.
    Rizza RA; Cryer PE; Gerich JE
    J Clin Invest; 1979 Jul; 64(1):62-71. PubMed ID: 36413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin.
    Gerich JE; Lorenzi M; Bier DM; Tsalikian E; Schneider V; Karam JH; Forsham PH
    J Clin Invest; 1976 Apr; 57(4):875-84. PubMed ID: 820717
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stimulation of splanchnic glucose production during exercise in humans contains a glucagon-independent component.
    Coker RH; Simonsen L; Bülow J; Wasserman DH; Kjaer M
    Am J Physiol Endocrinol Metab; 2001 Jun; 280(6):E918-27. PubMed ID: 11350773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.